Reclast label changed for renal dysfunction - ModernMedicine Print
ModernMedicine
FDA is now requiring prescribing information for Reclast(zoledronic acid, Novartis) to include a warning against use of the drug by patients with renal dysfunction. Specifically, the revised label lists as contraindications to use of Reclast: The

...